These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36181033)
101. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma. Duan Y; Zhang D J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370 [TBL] [Abstract][Full Text] [Related]
102. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma. Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284 [TBL] [Abstract][Full Text] [Related]
103. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173 [TBL] [Abstract][Full Text] [Related]
104. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
105. The Prediction of Necroptosis-Related lncRNAs in Prognosis and Anticancer Therapy of Colorectal Cancer. Xiao H; Pang Q; Wang Y; Lai S; Chen H Anal Cell Pathol (Amst); 2022; 2022():7158684. PubMed ID: 36199434 [TBL] [Abstract][Full Text] [Related]
106. A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients. Tao Z; Zhang E; Li L; Zheng J; Zhao Y; Chen X Bioengineered; 2021 Dec; 12(1):4259-4277. PubMed ID: 34304692 [TBL] [Abstract][Full Text] [Related]
107. Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma. Chen Q; Li ZL; Fu SQ; Wang SY; Liu YT; Ma M; Yang XR; Xie WJ; Gong BB; Sun T Aging (Albany NY); 2021 Jan; 13(3):3926-3944. PubMed ID: 33461173 [TBL] [Abstract][Full Text] [Related]
108. Effect of Aberrant Long Noncoding RNA on the Prognosis of Clear Cell Renal Cell Carcinoma. Wu H; Wu H; Sun P; Zhu D; Ma M; Fan W Comput Math Methods Med; 2021; 2021():6533049. PubMed ID: 34512796 [TBL] [Abstract][Full Text] [Related]
109. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer. Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z Front Immunol; 2022; 13():951455. PubMed ID: 36189298 [TBL] [Abstract][Full Text] [Related]
110. Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma. Zhang Y; Zhuang T; Xin Z; Sun C; Li D; Ma N; Wang X; Wang X Cells; 2022 Dec; 12(1):. PubMed ID: 36611858 [TBL] [Abstract][Full Text] [Related]
111. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
112. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis. Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X Front Immunol; 2022; 13():1085038. PubMed ID: 36618366 [TBL] [Abstract][Full Text] [Related]
113. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients. Li Z; Du G; Zhao R; Yang W; Li C; Huang J; Wen Z; Li H; Zhang B Medicine (Baltimore); 2021 Oct; 100(39):e27374. PubMed ID: 34596153 [TBL] [Abstract][Full Text] [Related]
114. Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma. Deng Y; Guo K; Tang Z; Feng Y; Cai S; Ye J; Xi Y; Li J; Liu R; Cai C; Tan Z; Zhang Y; Han Z; Zeng G; Zhong W Front Immunol; 2022; 13():1046790. PubMed ID: 36505457 [TBL] [Abstract][Full Text] [Related]
115. Risk coefficient model of necroptosis-related lncRNA in predicting the prognosis of patients with lung adenocarcinoma. Chen H; Xie Z; Li Q; Qu G; Tan N; Zhang Y Sci Rep; 2022 Jun; 12(1):11005. PubMed ID: 35768485 [TBL] [Abstract][Full Text] [Related]
116. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma. Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406 [TBL] [Abstract][Full Text] [Related]
117. Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma. Zhang D; Wang Y; Hu X DNA Cell Biol; 2020 Oct; 39(10):1799-1812. PubMed ID: 32716214 [TBL] [Abstract][Full Text] [Related]
118. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. Xie Y; Xu Z; Mei X; Shi W Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905 [TBL] [Abstract][Full Text] [Related]
119. A novel prognostic N Luo W; Lu J; Zheng X; Wang J; Qian S; Bai Z; Wu M Sci Rep; 2023 Oct; 13(1):18454. PubMed ID: 37891201 [TBL] [Abstract][Full Text] [Related]
120. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma. Yang K; Lu XF; Luo PC; Zhang J Biomed Res Int; 2018; 2018():9303486. PubMed ID: 30406146 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]